The FDA has approved the use of L-carnitine (by mouth or intravenously) treating L-carnitine deficiency caused by certain genetic diseases, end-stage kidney disease, and other disorders
cGAS In mammals, cGAS functions as a PRR that detects dsDNA aberrantly localized in the cytosol
doi: 10.1016/j.ccell.2018.07.014 96
Nalla AK, Estes N, Patel J, Rao JS
heart rate rose more in the higher-dose groups, peaked around week 24, then eased off
As with other agents in this class, semaglutide has a boxed warning regarding rodent thyroid C-cell tumor findings and the uncertain relevance to humans